Endocrinology
| Pheochromocytoma
Endocrinology
Pheochromocytoma
Maternal and fetal outcomes in phaeochromocytoma and pregnancy
book_2
Source:
ENDO 2022 - Oral Session
calendar_today
Published on Medfyle:
June 2022
import_contacts
5
min
In this medfyle
Pheochromocytomas and paragangliomas are rare tumors that can be very dangerous during pregnancy. Their prompt diagnosis and treatment is mandatory in achieving good maternal and fetal outcomes.
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
About this Medfyle
Read more
arrow_downward
Hide
arrow_upward
This is a highlights summary of an oral session given at the ENDO 2022 Annual Conference and presented by:
Irina Bancos, MD
Division of Endocrinology Mayo Clinic
Rochester, MN, USA
The content is produced by Infomedica, the official reporting partner of ENDO 2022.
The presenting authors of the original session had no part in the creation of this conference highlights summary.
